A detailed history of Wsfs Capital Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Wsfs Capital Management, LLC holds 1,809 shares of CRL stock, worth $339,621. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,809
Previous 1,809 -0.0%
Holding current value
$339,621
Previous $373,000 4.56%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$194.44 - $217.61 $13,027 - $14,579
-67 Reduced 3.57%
1,809 $354,000
Q4 2022

Feb 10, 2023

SELL
$197.11 - $250.07 $3,350 - $4,251
-17 Reduced 0.9%
1,876 $408,000
Q3 2022

Nov 03, 2022

BUY
$182.44 - $250.54 $3,283 - $4,509
18 Added 0.96%
1,893 $373,000
Q2 2022

Aug 10, 2022

BUY
$204.13 - $302.4 $13,472 - $19,958
66 Added 3.65%
1,875 $401,000
Q2 2018

Aug 10, 2018

BUY
$102.37 - $117.25 $185,187 - $212,105
1,809 New
1,809 $203,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.55B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Wsfs Capital Management, LLC Portfolio

Follow Wsfs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wsfs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wsfs Capital Management, LLC with notifications on news.